Navigation Links
Relapse in Risk Management System Claims the Life of Robertson

This report mainly brings to the notice of the common man that how official failings led to a man being bludgeoned to death by a psychiatric patient// with a history of violence. Stuart Robertson was killed by James Smith, who was on conditional discharge from Leverndale Hospital in Glasgow, in October 2004. This report mainly gives us an insight of how there was no systematic approach to risk assessment.

There was a failure to respond adequately to clear signs that Smith's mental illness had relapsed while he was in the care of community-based mental health services. This report was by the Mental Welfare Commission for Scotland. It asks for a series of changes to be implemented by the Scottish Executive, NHS Greater Glasgow and social work chiefs in Glasgow. Smith, 46, had suffered mental problems since 1991. He was jailed for life in Glasgow in November after he admitted the homicide of Mr Robertson.

He had killed Mr Robertson, who also had a history of mental illness, by bludgeoning him to death with a hammer in Pollok Park, Glasgow. The report said that Smith's condition had relapsed in the summer of 2004 but there was no systematic approach to risk assessment in his care and supervision, and an inadequate focus by some of those involved in his care. There was no satisfactory strategy planned to deal with any relapse in his illness.

In the months before the killing he showed signs of relapse but was not recalled to hospital. The Executive, NHS Greater Glasgow and Glasgow City Council acknowledged it had identified weaknesses as the basic risk management was not proper. The deputy health minister, Lewis Macdonald, said that all steps to address the deficiencies identified are being done and the public need not worry about it.


'"/>




Page: 1

Related medicine news :

1. Medications to Prevent Relapse to Cocaine Use
2. Alcoholism Drug Fails To Prevent Drinking Relapses
3. Treatment For Prostate Cancer Relapse Linked To Marital Status
4. New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse
5. Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.
6. Rogue Mammary Stem Cells Could Hold Key To Breast Cancer Relapse
7. Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug
8. Leftover Cancer Cells May Dictate Breast Cancer Relapse
9. Kids are More Prone to Tonsillitis Relapse
10. Colon Cancer Relapse Mainly Caused by Stem Cells
11. ALL Relapses in Most Children After Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... ... February 26, 2017 , ... This is an ... world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 (house ... is the globally recognised standard that sets out requirements for the technical competence ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports improved ... study released today at the 1st Pan American Parkinson’s and Movement Disorders Congress. ... effective in improving cognitive function in PD patients. This study, led by Ibarretxe-Bilbao ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , The New Jersey ... as well as advocacy for the state and region‘s technology businesses, hosted their ... The Council's Innovation Forecast event highlights innovation throughout the region from small to ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... AMSTERDAM , Feb. 27, 2017   ... AEX: PHIA), a global leader in health technology, ... and Drug Administration (FDA) to market its ElastQ ... EPIQ family of ultrasound systems. ElastQ Imaging enables ... stiffness, which is essential for the diagnosis of ...
(Date:2/27/2017)... 27, 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ... company focused on tissue protection, repair and regeneration, ... Co., Ltd., received a positive response from the ... design for RGN-137 to treat epidermolysis bullosa ("EB"). ... incorporates Thymosin beta 4 ("Tß4") as the active ...
(Date:2/27/2017)... 2017  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: ... M.D., Ph.D., as President and Chief Executive Officer (CEO) and ... Dr. Craig succeeds Richard Love , interim President and ... of Directors.  Dr. Craig has over 20 years of experience ... and Europe . "On behalf ...
Breaking Medicine Technology: